UK – Hampden Underwriting plc, which provides investors with a limited liability direct investment into the Lloyd’s insurance market, is pleased to announce the appointment of Andrew Christie as a non-executive director of the Company with immediate effect. Andrew is a founding partner of corporate finance advisory firm, Smith Square Partners and has nearly 30 years’ experience in corporate finance. Prior to Smith Square Partners, he was a Managing Director in the Investment Banking Division of Credit Suisse Europe and prior to that he was head of investment banking in Asia Pacific for Credit Suisse First Boston and Barclays de Zoete Wedd. Andrew is a non-executive director of FTSE 250 company, Elementis plc.
Sir Michael Oliver, Chairman of Hampden Underwriting, said: “We are delighted to welcome Andrew to the Hampden board and look forward to the benefit of his experience as the development of the Company continues.”
Andrew Hildred Christie (aged 57) is currently a director/partner of the following companies/partnerships: Smith Square Partners LLP; Elementis plc; Tedworth North Management Limited; Tedworth Square North Limited; Nomina No 174 LLP; Nomina No 371 LLP; Conservation Education & Research Trust, and has been a director of the following companies in the last five years: Ark Therapeutics Group plc.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
